IMARC Group, a leading market research company, has recently releases report titled “Botulinum Toxin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global botulinum toxin market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
What is the outlook for the botulinum toxin market?
The global botulinum toxin market size reached US$ 5.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.4 Billion by 2028, exhibiting a growth rate (CAGR) of 7.7% during 2023-2028.
What is botulinum toxin?
Botulinum toxin refers to a neurotoxin manufactured by the bacterium Clostridium botulinum, which is an anaerobic, gram-positive, spore-forming rod that is commonly found in soil, plants, water, the intestinal tracts of several animals, etc. Botulinum toxin plays a significant role in the management of various medical conditions, such as strabismus and focal dystonia, hemifacial spasm, headaches, hypersalivation, hyperhidrosis, spastic movement disorders, etc. It is also utilized for numerous cosmetic purposes, including to temporarily reduce frown lines, creases, and wrinkles on the face, chin, neck, chest, etc.
Request to Get the Sample Report: https://www.imarcgroup.com/botulinum-toxin-market/requestsample
Botulinum Toxin Market Trends and Growth Drivers:
The increasing product utilization in the treatment of numerous dermatological conditions, such as abnormal gland activity and overactive smooth muscles, is primarily driving the botulinum toxin market across the globe. Additionally, the growing beauty consciousness among individuals and their willingness to undergo reconstructive and cosmetic surgeries are also propelling the market growth.
Apart from this, the inflating levels of disposable incomes and urbanization, coupled with the emerging trend of cosmetic tourism, are acting as significant growth-inducing factors. Moreover, the expanding geriatric population is further catalyzing the market growth since the skin becomes more susceptible to sagging and wrinkles with age. In addition to this, various technological innovations, such as the development of new potent toxins to enhance the effectiveness of antigenic dose, are projected to bolster the botulinum toxin market in the coming years.
Who are the key players operating in the industry?
The report covers the major market players including:
- AbbVie Inc.
- Eisai Co. Ltd
- Evolus Inc
- Galderma SA
- HUGEL Inc.
- Ipsen Group
- Medytox Inc.
- Merz Pharma GmbH and Co. KGaA
- Metabiologics Inc.
- Revance Therapeutics Inc.
Market Segmentation:
The report has segmented the botulinum toxin market on the basis of type, application, end user and region.
Breakup by Type:
- Toxin Type A
- Toxin Type B
Application:
- Therapeutics
- Aesthetics
End User:
- Hospitals and Clinics
- Dermatology Clinics
- Spas and Cosmetic Centres
Regional Outlook:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Explore Full Report Description At: https://www.imarcgroup.com/botulinum-toxin-market
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group
